Published by Josh White on 28th February 2018
(ShareCast News) - Specialty pharmaceutical company Midatech announced on Wednesday that the European Medicines Agency has granted Orphan Drug Designation for its advanced liver cancer drug candidate, MTD119.
URL: http://www.digitallook.com/dl/news/story/27127331/...